top of page


The path from target to Investigational New Drug/Molecular Diagnostics is long and complex....

Finding functional, target-binding leads isn’t enough!!!!

Nanobodies are synthetic single domain, engineered target-binding fragments that has the potential to replace current animal-harvested antibodies for

molecular diagnostics applications in human healthcare, animal breeding, agriculture and food safety.

bioLOCKEY has taken the science of Nanobody discovery to another level by using bio-computational technique to design and optimise the binding between Nanobody and target molecules in a 3D virtual environment – at least 20X faster and cheaper than conventional lab-based methods.

Find optimal clinical candidates with speed and precision.

Integrated high-throughput nanobody assessment and computational methods increase the likelihood of finding optimal development candidates sooner.

6 views0 comments


bottom of page